AccuType® CP for early identification
of clopidogrel responders, even before
starting therapy:
- May help guide treatment strategy for patients
being considered for, or already taking,
clopidogrel - Can help you determine if dosage adjustments
are needed prior to stent replacement
or other procedures
Get the
Results that
Help Guide
Treatment
WATCH

“Pharmacogenomics in Cardiovascular Disease and Clopidogrel Response Testing Updates”
Dr. Matthew Price and Dr Jay Wohlgemuth.
GET UPDATES

Sign up to receive the latest scientific updates and test information.